No abstract available
MeSH terms
-
Aged
-
Antibodies / blood*
-
Biomarkers / blood
-
ChAdOx1 nCoV-19 / administration & dosage
-
ChAdOx1 nCoV-19 / adverse effects*
-
Humans
-
Immunoglobulins, Intravenous / administration & dosage
-
Male
-
Middle Aged
-
Platelet Factor 4 / immunology*
-
Pulmonary Embolism / chemically induced*
-
Pulmonary Embolism / diagnosis
-
Pulmonary Embolism / drug therapy
-
Pulmonary Embolism / immunology
-
Thrombocytopenia / chemically induced*
-
Thrombocytopenia / diagnosis
-
Thrombocytopenia / drug therapy
-
Thrombocytopenia / immunology
-
Treatment Outcome
-
Vaccination / adverse effects*
-
Venous Thromboembolism / chemically induced*
-
Venous Thromboembolism / diagnosis
-
Venous Thromboembolism / drug therapy
-
Venous Thromboembolism / immunology
-
Venous Thrombosis / chemically induced*
-
Venous Thrombosis / diagnosis
-
Venous Thrombosis / drug therapy
-
Venous Thrombosis / immunology
Substances
-
Antibodies
-
Biomarkers
-
Immunoglobulins, Intravenous
-
PF4 protein, human
-
Platelet Factor 4
-
ChAdOx1 nCoV-19